LVTX fundamentals
An in-depth look to LAVA Therapeutics N.V. operating, investing, and financing activities
LVTX free cash flow for Q4 23 is -9.71 M USD. For 2023, LVTX free cash flow was -39.7 M USD and operating cash flow was -38.97 M USD.
Q1 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM